Results 231 to 240 of about 9,460,673 (364)
NON - DESCENT VAGINAL HYSTERECTOMY FOR BENIGN GYNAECOLOGICAL DISEASE – A PROSPECTIVE STUDY
C Chandana+2 more
openalex +1 more source
Obstetric characteristics and maternal outcomes of early second‐trimester placenta accreta spectrum
Abstract Objective To describe early second‐trimester placenta accreta spectrum (PAS) management and outcomes. Methods This cross‐sectional study queried the US Healthcare Cost and Utilization Project's National Inpatient Sample from 2016 to 2021, finding 905 cases with a diagnosis of PAS between 14 and 22 weeks of gestation and in‐hospital management.
Mihiri S. Karunaratne+8 more
wiley +1 more source
Health disorders in menopausal women: microbiome alterations, associated problems, and possible treatments. [PDF]
Lin F, Ma L, Sheng Z.
europepmc +1 more source
Cancer of the vulva: 2025 update
Abstract Vulvar cancer is an uncommon gynecological malignancy primarily affecting postmenopausal women. No specific screening exists and the most effective strategy to reduce the incidence of vulvar cancer is the opportune treatment of predisposing and preneoplastic lesions associated with its development.
Alexander B. Olawaiye+3 more
wiley +1 more source
Temporal dynamics of the vaginal microbiome and host immune markers before, during, and after metronidazole treatment for bacterial vaginosis. [PDF]
Williams A+6 more
europepmc +1 more source
Protective effect of rooming‐in on postpartum hemorrhage: A propensity score analysis
Abstract Objective This study investigates the effect of rooming‐in on postpartum hemorrhage (PPH) and other adverse maternal postpartum outcomes. Methods A retrospective study was performed on all healthy women with singleton term pregnancies at a tertiary medical center between 2013 and 2022.
Natav Hendin+7 more
wiley +1 more source
Abstract Background The introduction of immunoglobulin G (IgG) anti‐D prophylaxis for Rhesus D (RhD)‐negative women has substantially reduced the incidence of RhD alloimmunization and hemolytic disease of the fetus and newborn in Europe by 85%, transforming fetal health outcomes.
Kristina Gemzell‐Danielsson+11 more
wiley +1 more source